O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate   、                                                                                      
(R)-4-((3-methyl-4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methyl)-1H-pyrazole-3-carboxylic acid   、                                                                                      
4-氨基吡啶   、                                                                                      
N,N-二异丙基乙胺                                                                                                                                                              在
                                                                                                                                                                                 
acetonitrile-water   、                                                                                                  
三氟乙酸   、                                                                                                  
(R)-4-((3-methyl-4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methyl)-N-(pyridin-4-yl)-1H-pyrazole-3-carboxamide   、                                                                                                  
乙酸乙酯                                                                                                                                  作用下,
                                                                                                                以
                                                                                         
N,N-二甲基甲酰胺                                                                                  为溶剂,
                                                                                                                                                    反应 16.0h,
                                                                                                                以to give (R)-4-((3-methyl-4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methyl)-N-(pyridin-4-yl)-1H-pyrazole-3-carboxamide, 1H NMR (DMSO-d6) δ 1.13 (d, 3H, J=6.8 Hz), 2.08 (m, 1H), 2.18 (m, 1H), 2.79 (d, 1H, J=11.2 Hz), 3.02 (d, 1H, J=10.8 Hz), 3.11 (t, 1H, J=12 Hz), 3.70 (d, 1H, J=13.6 Hz), 3.81 (d, 1H, J=13.6 Hz), 4.19 (d, 1H, J=12.0 Hz), 4.57 (b, 1H), 6.88 (d, 1H, J=9.6 Hz), 7.77 (d, 1H, J=9.6 Hz), 7.79 (d, 2H, J=6.4 Hz), 7.84 (s, 1H), 8.40 (s, 1H), 8.44 (d, 2H, J=6.4 Hz), 10.69 (s, 1H)的产率得到(R)-4-((3-methyl-4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methyl)-N-(pyridin-4-yl)-1H-pyrazole-3-carboxamide